These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35658399)

  • 1. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor.
    Li H; Urs NM; Horenstein N
    J Comput Aided Mol Des; 2023 Jun; 37(5-6):227-244. PubMed ID: 37060492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Functional-Selectivity Relationship Studies of Novel Apomorphine Analogs to Develop D1R/D2R Biased Ligands.
    Park H; Urs AN; Zimmerman J; Liu C; Wang Q; Urs NM
    ACS Med Chem Lett; 2020 Mar; 11(3):385-392. PubMed ID: 32184974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing Functionally Selective Noncatechol Dopamine D
    Martini ML; Ray C; Yu X; Liu J; Pogorelov VM; Wetsel WC; Huang XP; McCorvy JD; Caron MG; Jin J
    ACS Chem Neurosci; 2019 Sep; 10(9):4160-4182. PubMed ID: 31387346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy.
    Allen JA; Yost JM; Setola V; Chen X; Sassano MF; Chen M; Peterson S; Yadav PN; Huang XP; Feng B; Jensen NH; Che X; Bai X; Frye SV; Wetsel WC; Caron MG; Javitch JA; Roth BL; Jin J
    Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18488-93. PubMed ID: 22025698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamics simulation of biased agonists at the dopamine D2 receptor suggests the mechanism of receptor functional selectivity.
    Montgomery D; Campbell A; Sullivan HJ; Wu C
    J Biomol Struct Dyn; 2019 Aug; 37(12):3206-3225. PubMed ID: 30124143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists.
    Chen X; McCorvy JD; Fischer MG; Butler KV; Shen Y; Roth BL; Jin J
    J Med Chem; 2016 Dec; 59(23):10601-10618. PubMed ID: 27805392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
    Peterson SM; Pack TF; Caron MG
    PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor.
    Gray DL; Allen JA; Mente S; O'Connor RE; DeMarco GJ; Efremov I; Tierney P; Volfson D; Davoren J; Guilmette E; Salafia M; Kozak R; Ehlers MD
    Nat Commun; 2018 Feb; 9(1):674. PubMed ID: 29445200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor.
    Free RB; Chun LS; Moritz AE; Miller BN; Doyle TB; Conroy JL; Padron A; Meade JA; Xiao J; Hu X; Dulcey AE; Han Y; Duan L; Titus S; Bryant-Genevier M; Barnaeva E; Ferrer M; Javitch JA; Beuming T; Shi L; Southall NT; Marugan JJ; Sibley DR
    Mol Pharmacol; 2014 Jul; 86(1):96-105. PubMed ID: 24755247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidation of G-protein and β-arrestin functional selectivity at the dopamine D2 receptor.
    Peterson SM; Pack TF; Wilkins AD; Urs NM; Urban DJ; Bass CE; Lichtarge O; Caron MG
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7097-102. PubMed ID: 25964346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered D2R Variants Reveal the Balanced and Biased Contributions of G-Protein and β-Arrestin to Dopamine-Dependent Functions.
    Rose SJ; Pack TF; Peterson SM; Payne K; Borrelli E; Caron MG
    Neuropsychopharmacology; 2018 Apr; 43(5):1164-1173. PubMed ID: 29068002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Arrestin biased dopamine D2 receptor partial agonists: Synthesis and pharmacological evaluation.
    Männel B; Hübner H; Möller D; Gmeiner P
    Bioorg Med Chem; 2017 Oct; 25(20):5613-5628. PubMed ID: 28870802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
    Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
    Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D
    Martini ML; Liu J; Ray C; Yu X; Huang XP; Urs A; Urs N; McCorvy JD; Caron MG; Roth BL; Jin J
    J Med Chem; 2019 Apr; 62(7):3753-3772. PubMed ID: 30875219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D
    Bonifazi A; Yano H; Ellenberger MP; Muller L; Kumar V; Zou MF; Cai NS; Guerrero AM; Woods AS; Shi L; Newman AH
    J Med Chem; 2017 Apr; 60(7):2890-2907. PubMed ID: 28300398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-Like Efficacy of Dopamine D
    Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
    Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.
    Chen X; Sassano MF; Zheng L; Setola V; Chen M; Bai X; Frye SV; Wetsel WC; Roth BL; Jin J
    J Med Chem; 2012 Aug; 55(16):7141-53. PubMed ID: 22845053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.
    Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.